{"id":"https://openalex.org/W3083166759","doi":"https://doi.org/10.1158/1538-7445.am2020-5262","title":"Abstract 5262: Identifying the role of AXL in fusion kinase inhibitor resistant non-small cell lung cancer","display_name":"Abstract 5262: Identifying the role of AXL in fusion kinase inhibitor resistant non-small cell lung cancer","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083166759","doi":"https://doi.org/10.1158/1538-7445.am2020-5262","mag":"3083166759"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-5262","doi":"https://doi.org/10.1158/1538-7445.am2020-5262","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5262","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025500350","display_name":"Tara L. Peters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tara Peters","raw_affiliation_strings":["1University of Colorado, Anschutz Medical Campus, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Colorado, Anschutz Medical Campus, Aurora, CO;","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073550585","display_name":"Anastasios Dimou","orcid":"https://orcid.org/0000-0002-3950-3305","observed_orcids":["https://orcid.org/0000-0002-3950-3305"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anastasios Dimou","raw_affiliation_strings":["2Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100753119","display_name":"Anh Tuan Le","orcid":"https://orcid.org/0000-0003-4221-0914","observed_orcids":["https://orcid.org/0000-0003-4221-0914"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anh Le","raw_affiliation_strings":["1University of Colorado, Anschutz Medical Campus, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Colorado, Anschutz Medical Campus, Aurora, CO;","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034705456","display_name":"Robert Charles Doebele","orcid":"https://orcid.org/0000-0001-6728-6857","observed_orcids":["https://orcid.org/0000-0001-6728-6857"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Doebele","raw_affiliation_strings":["1University of Colorado, Anschutz Medical Campus, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Colorado, Anschutz Medical Campus, Aurora, CO;","institution_ids":["https://openalex.org/I51713134"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"5262","last_page":"5262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axl-receptor-tyrosine-kinase","display_name":"AXL receptor tyrosine kinase","score":0.925000011920929},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9120000004768372},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/alk-fusion","display_name":"ALK fusion","score":0.902999997138977},{"id":"https://openalex.org/keywords/ros1-rearrangement","display_name":"ROS1 rearrangement","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ret-fusion","display_name":"RET fusion","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.871999979019165},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9340000152587891},{"id":"https://openalex.org/keywords/r428","display_name":"R428","score":0.9739999771118164},{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.7419999837875366},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.7009999752044678},{"id":"https://openalex.org/keywords/mesenchymal-phenotype","display_name":"mesenchymal phenotype","score":0.777999997138977},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.907575249671936},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7786880731582642},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.7051291465759277},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.6577127575874329},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5882291197776794},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.5497520565986633},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5479786396026611},{"id":"https://openalex.org/C5364575","wikidata":"https://www.wikidata.org/wiki/Q17836543","display_name":"AXL receptor tyrosine kinase","level":5,"score":0.5081007480621338},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4675413966178894},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.45690906047821045},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.41099661588668823},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40610387921333313},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38812553882598877},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.38561075925827026},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.38100746273994446},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3405637741088867},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32391828298568726},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.17530575394630432},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.1496962308883667},{"id":"https://openalex.org/C157333092","wikidata":"https://www.wikidata.org/wiki/Q902835","display_name":"JAK-STAT signaling pathway","level":4,"score":0.08758410811424255},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.056274235248565674},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-5262","doi":"https://doi.org/10.1158/1538-7445.am2020-5262","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5262","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8299999833106995,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2767476799","https://openalex.org/W2235360349","https://openalex.org/W2741279242","https://openalex.org/W1983774108","https://openalex.org/W4214919327","https://openalex.org/W7096917794","https://openalex.org/W2763670880","https://openalex.org/W2027756679","https://openalex.org/W1543222107","https://openalex.org/W2954772194"],"abstract_inverted_index":{"Abstract":[0],"Chromosomal":[1],"rearrangements":[2],"involving":[3],"ALK,":[4,120,141,291],"ROS1,":[5,121,292],"RET":[6,123,144,251,294],"and":[7,39,78,97,108,122,167,183,194,212,259,263,293,301,359],"others":[8],"generate":[9],"novel":[10],"fusion":[11,198,295,333],"kinases":[12],"which":[13,55,267],"comprise":[14],"approximately":[15],"10%":[16],"of":[17,36,54,114,134,256,287,330,344,348],"the":[18,95,112,171,215,264,328,345,349],"oncogenic":[19],"drivers":[20],"in":[21,32,70,73,116,197,209,332],"lung":[22,136,298,339],"adenocarcinoma.":[23],"Several":[24],"tyrosine":[25,64,247],"kinase":[26,65,199,296,334],"inhibitors":[27],"(TKIs)":[28],"are":[29,230,261],"approved":[30],"or":[31,100,143],"development":[33],"for":[34,45,181,304,310,352],"each":[35],"these":[37],"oncogenes":[38],"have":[40],"shown":[41],"marked":[42],"clinical":[43,308],"improvement":[44],"patients,":[46],"but":[47],"resistance":[48,88,118,155,289],"inevitably":[49],"occurs,":[50],"a":[51,62,250,284,307],"significant":[52],"proportion":[53],"is":[56,61,67,125,283],"not":[57,126],"currently":[58],"druggable.":[59],"AXL":[60,85,115,150,172,241,258,281,305,331],"receptor":[63,246],"that":[66,229,280],"often":[68],"upregulated":[69],"resistant":[71,201,210,216,253,336],"cancers":[72],"response":[74],"to":[75,89,105,119,156,223,233,274,313],"both":[76,257],"chemotherapy":[77],"targeted":[79,90],"therapies":[80],"such":[81,178],"as":[82,159,161,179,306],"EGFR":[83,260],"inhibitors.":[84],"can":[86,268],"promote":[87],"therapy":[91,312],"by":[92],"signaling":[93],"through":[94],"MAPK":[96],"Akt":[98,207],"pathways":[99],"heterodimerizing":[101],"with":[102,154,175,244],"other":[103,245],"receptors":[104,265],"maintain":[106],"growth":[107],"survival":[109],"signaling.":[110],"However,":[111],"role":[113,329],"mediating":[117],"TKIs":[124],"well":[127,160],"understood.":[128],"In":[129,249],"screening":[130],"our":[131],"unique":[132],"panel":[133],"patient-derived":[135],"adenocarcinoma":[137,299],"cell":[138,186,202,217,227,338],"lines":[139,218,228],"harboring":[140],"ROS1":[142,184],"gene":[145],"fusions,":[146],"we":[147,213,238,278],"found":[148,214],"elevated":[149,262],"expression":[151,255],"was":[152,188],"correlated":[153],"cognate":[157],"TKIs,":[158],"mesenchymal":[162],"features":[163],"including":[164],"spindle":[165],"morphology":[166],"vimentin":[168],"expression.":[169],"Combining":[170],"inhibitor":[173,200,252,335],"R428":[174],"TKI":[176,288],"treatment,":[177],"crizotinib":[180],"ALK":[182],"driven":[185,297],"lines,":[187],"effective":[189],"at":[190],"inhibiting":[191],"colony":[192],"formation":[193],"wound":[195],"healing":[196],"lines.":[203],"Combination":[204],"treatment":[205],"downregulates":[206],"phosphorylation":[208],"cells,":[211],"were":[219],"also":[220,239],"more":[221],"sensitive":[222,232],"PI3K":[224],"inhibition":[225],"than":[226],"still":[231],"their":[234],"specific":[235],"TKI.":[236],"Interestingly,":[237],"identified":[240],"cross":[242],"talk":[243],"kinases.":[248],"model":[254],"interact,":[266],"be":[269],"disrupted":[270],"upon":[271],"EGF":[272],"stimulation,":[273],"drive":[275],"resistance.":[276,316],"Collectively,":[277],"show":[279],"upregulation":[282],"common":[285],"marker":[286],"among":[290],"models,":[300],"provide":[302],"rationale":[303],"target":[309],"combination":[311],"overcome":[314],"drug":[315],"Citation":[317],"Format:":[318],"Tara":[319],"Peters,":[320],"Anastasios":[321],"Dimou,":[322],"Anh":[323],"Le,":[324],"Robert":[325],"Doebele.":[326],"Identifying":[327],"non-small":[337],"cancer":[340],"[abstract].":[341],"In:":[342],"Proceedings":[343],"Annual":[346],"Meeting":[347],"American":[350],"Association":[351],"Cancer":[353,365],"Research":[354],"2020;":[355],"2020":[356],"Apr":[357],"27-28":[358],"Jun":[360],"22-24.":[361],"Philadelphia":[362],"(PA):":[363],"AACR;":[364],"Res":[366],"2020;80(16":[367],"Suppl):Abstract":[368],"nr":[369],"5262.":[370]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-09-11T00:00:00"}